Selected Publications
White L, Lucas G, Richards A, Purves D. Cerebral Asymmetry and Handedness. Nature 1994;368:197-8.
Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: a comparison of clinical features and outcomes. Clin Infect Dis 1998;26:1127-33.
Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-7.
Lucas GM, Tucker P, Merz WG. Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutropenia. Clin Infect Dis 1999;29:1594-6.
Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 2001;27:251-9.
Lucas GM, Chaisson RE, Moore RD. Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz. AIDS 2001;15:1679-86.
Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002;16:767-774.
Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden? AIDS Patient Care STDS 2002;16:527-535.
Lucas GM, Chaisson RE, Moore RD. Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study. J Acquir Immune Defic Syndr 2003;33:321-328.
Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004;18:541-546.
Lucas GM, Gallant JE, Moore RD. Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing. AIDS 2004;18:1539-1548.
Lucas GM, Weidle PJ, Hader S, Moore RD. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a non-randomized comparative study. Clin Infect Dis 2004;38 Suppl5:S409-S413.
Lucas GM, Wu AW, Cheever LW. Adherence to antiretroviral therapy: an update of current concepts. Current HIV/AIDS reports 2004;1:172-180.
Lucas GM. Antiretroviral adherence, drug resistance, viral fitness, and HIV disease progression: a tangled web is woven. J Antimicrob Chemother 2005;55:413-416.
Vlahov D, Galai N, Safaeian M, Duggal P, Lin M, Winkler C, Galea S, Kirk GD, Lucas GM, Sterling TR. Effectiveness of HAART among injection drug users with late-stage HIV infection. Am J Epidemiol 2005;161:999.
Moore RD, Keruly JC, Gebo KA, Lucas GM. An improvement in virologic response to HAART in clinical practice from 1996-2002. J Acquir Immune Defic Syndr 2005 Jun 1;39(2):195-8.
Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol 2006;163:412-420.
Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990 – 2003. AIDS 2006;20:437-444.
Lucas GM, Mullen BA, Weidle PJ, Hader H, McCaul ME, Moore RD. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis 2006;42:1628-1635.
Sullivan LE, Bruce RD, Halitiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin, DA. Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clin Infect Dis 2006;43:S191-S196.
Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clin Infect Dis 2006;43:S197-S215.
Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence of, risk factors for, clinical presentation and one-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 2006;43:426-432.
Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 2006;20:2361-2369.
Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy 2007;18:262-270.
Lucas GM, Mullen BA, McCaul ME, Weidle PJ, Hader S, Moore RD. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered therapy. AIDS Patient Care STDS 2007;21:564-574.
Lucas GM, Mehta SH, O’Driscoll P, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. End-stage renal disease and chronic kidney disease in a cohort of African American HIV-infected and at-risk HIV-seronegative participants. AIDS 2007:21:2435-2443.
Celentano DD, Lucas G. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clin Infect Dis 2007;45:S318-23.
Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 2007;45:1625-1632.
Fine DM, Garg N, Haas M, Rahman MH, Lucas GM, Scheel PJ, Atta MG. Cocaine use and hypertensive renal changes in HIV-infected individuals. Clin J Am Soc Nephrol 2007;2:1125-1130.
Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, Atta MG. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 2008;28:478-486.
Riedel DJ, Gebo KA, Moore RD, Lucas GM. A 10-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort. AIDS Patient Care STDS [in press].
Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence and progression to end-stage renal disease in HIV-infected individuals: a tale of two races. J Infect Dis [in press].
Fine DM, Perazella MA, Lucas GM, Atta MG. Kidney biopsy in HIV: beyond HIVAN. Am J Kidney Dis [in press].
